Clinical trial
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed…
NCT00198978 · Goethe University, Other · Completed
Key facts
| NCT number | NCT00198978 |
|---|---|
| Title | German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Official title | Multicenter Study To Optimize Treatment in Elderly Patients (> 55 Years, No Upper Age Limit) With Acute Lymphoblastic Leukemia (GMALL Elderly 1/2003)(Amend 2) |
| Lead sponsor | Goethe University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Dexamethasone / Prednisolone, Cytarabine, Idarubicin, Granulocyte-Colony-Stimulating Factor, Mercaptopurine, Methotrexate, Rituximab, HDARAC, Vincristine and 2 more |
| Enrollment | 377 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2014 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 20, 2023 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: